ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2223

Can Fibromyalgia be Empirically Defined By the Number of Pain Locations Plus Symptoms?

Robert M. Bennett1, Kim D. Jones1, Jonathan H. Aebischer2 and Amanda W. St. John3, 1Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, 2Department of Family Medicine, Oregon Health & Science University, Portland, OR, 3Anesthesiology and Pain Medicine, Oregon Health & Science University, Portland, OR

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: diagnosis and fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes - Poster II: Clinical Focus

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Both the revised 2010 FM criteria (Wolfe et al.) and the 2013 FM criteria (Bennett et al.), rely on counting the number of pain locations plus a certain number of symptoms as presumptive evidence for the patient having widespread pain. However, little is known about how these criteria operate in the primary setting.

Methods: A descriptive cross sectional study assessed adults being seen in2 primary care clinics. Data sources included chart review, history, physical exam and patient-completed surveys.

Results: Altogether 357 patients were studied (all female, age 50 ± 16.3 years). Chart review revealed that 50 patients carried a diagnosis of FM in their medical record. However, only 17 patients fulfilled the 2013 FM diagnostic criteria. A comparison of the 2 diagnostic groups is shown in the following table:

Test

Clinician diagnosed  FM (n=50)

Criteria diagnosed  FM (n=17)

P Value

Number of pain locations

12.7±7.86

15 ± 4.1± 4.09

<0.001

SIQR symptom score

32.7±9.4

36.1± 8.6

0.17

BP pain threshold

132.3±51.5

122.1±18.4

0.47

Total SIQR score

66.7±18.4

62.5 ± 18.4

0.41

SIQR function

50.2±20.10

52.7±20.10

0.67

SIQR pain

6.5± 1.97

7.1 ± 2.01

0.26

SIQR tenderness

6.8±32.86

7.9±2.49

0.13

SIQR sleep

6.5±3.67

8.1 ± 2.35

0.99

Environmental sensitivity

6.8±3.21

7.5±3.06

0.42

“I have a persistent deep aching pain over most of my body.”

7.9±2.59

9.1 ± 1.13

<0.01

Conclusion: These results show that clinician diagnosed and criteria diagnosed patients were very similar in most descriptive variables. The 2013 criteria are based on a pain locations score >16 and a SIQR symptom score of>21. It is seen that the symptoms score does not account for the difference in diagnosis, but the number of pain locations was significantly less in the clinician diagnosed FM. Thus it appears that there is a group of “fibromyalgia like” patients that differ from 2013 criteria patients only in the number of pain locations. This raises 3 questions: 1. What should we call the clinic diagnosed patients who are symptomatically similar but differ from criteria diagnosed patients only in the number of pain locations? 2. Is the number of pain locations representative of the concept of widespread pain? 3. Would the concept of widespread pain be better defined by a question, such as seen in the last row?


Disclosure: R. M. Bennett, None; K. D. Jones, None; J. H. Aebischer, None; A. W. St. John, None.

To cite this abstract in AMA style:

M. Bennett R, D. Jones K, H. Aebischer J, W. St. John A. Can Fibromyalgia be Empirically Defined By the Number of Pain Locations Plus Symptoms? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/can-fibromyalgia-be-empirically-defined-by-the-number-of-pain-locations-plus-symptoms/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/can-fibromyalgia-be-empirically-defined-by-the-number-of-pain-locations-plus-symptoms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology